LOGAN, Utah--(BUSINESS WIRE)--ELITechGroup Biomedical Systems (EBS), known for worldwide transformation and innovation of sweat testing with the Webster Sweat Inducer and Macroduct® Sweat Collection System, endorsed by the U.S. Cystic Fibrosis Foundation and other global CF associations, announces the release of the new FDA-cleared Macroduct® Advanced Sweat Collection System.
Features of the new Macroduct Advanced include a touch screen user interface with built-n step-by-step graphical instructions that further standardize pilocarpine iontophoresis and sweat collection for optimum results. In addition, the revised shape of electrodes and Macroduct collector offer greater convenience when working with neonates and toddlers with small limbs. This system truly is sweat testing at its best while enhancing laboratory workflow in meeting protocols and traceability requirements with flexible options for data management.
“More than 5 million sweat tests have been performed with the existing Macroduct Sweat Collection System. This new Macroduct Advanced proves our commitment to ongoing innovation to improve patient care by developing market-leading diagnostic products. Laboratories that use our products for sweat testing do so with confidence as a result of our superior features that test and troubleshoot for optimal results,” says Bryce McEuen, Vice President, Biomedical Systems.
Sweat testing at its best has arrived. Visit MacroductAdvanced.com.
About ELITechGroup Biomedical Systems
ELITechGroup Biomedical Systems (EBS) is the world leader for laboratory diagnosis of cystic fibrosis with the proven products for sweat stimulation, collection, and analysis. The company is also a key player in supporting global laboratories with the world’s most advanced cytocentrifuge rotor, slide stainers, and osmometers.
Learn more about the ELITechGroup by visiting ELITechGroup.com.